Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Annals of the Rheumatic Diseases
Rachel B JonesEuropean Vasculitis Society (EUVAS)

Abstract

The RITUXVAS trial reported similar remission induction rates and safety between rituximab and cyclophosphamide based regimens for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis at 12 months; however, immunosuppression maintenance requirements and longer-term outcomes after rituximab in ANCA-associated renal vasculitis are unknown. Forty-four patients with newly diagnosed ANCA-associated vasculitis and renal involvement were randomised, 3:1, to glucocorticoids plus either rituximab (375 mg/m(2)/week×4) with two intravenous cyclophosphamide pulses (n=33, rituximab group), or intravenous cyclophosphamide for 3-6 months followed by azathioprine (n=11, control group). The primary end point at 24 months was a composite of death, end-stage renal disease and relapse, which occurred in 14/33 in the rituximab group (42%) and 4/11 in the control group (36%) (p=1.00). After remission induction treatment all patients in the rituximab group achieved complete B cell depletion and during subsequent follow-up, 23/33 (70%) had B cell return. Relapses occurred in seven in the rituximab group (21%) and two in the control group (18%) (p=1.00). All relapses in the rituximab group occurred after B cell return. At 24 months, rates of ...Continue Reading

References

Oct 9, 2002·The Journal of Clinical Investigation·Hong XiaoJ Charles Jennette
Jul 4, 2003·The New England Journal of Medicine·David JayneUNKNOWN European Vasculitis Study Group
Jun 22, 2007·Journal of the American Society of Nephrology : JASN·David R W JayneUNKNOWN European Vasculitis Study Group
Aug 18, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Madeleine V PahlNosratola D Vaziri
Jul 22, 2010·The New England Journal of Medicine·Rachel B JonesUNKNOWN European Vasculitis Study Group
Jul 22, 2010·The New England Journal of Medicine·John H StoneUNKNOWN RAVE-ITN Research Group
Sep 29, 2011·Arthritis and Rheumatism·Michael WalshUNKNOWN European Vasculitis Study Group
Aug 2, 2013·The New England Journal of Medicine·Ulrich SpecksUNKNOWN RAVE-ITN Research Group

❮ Previous
Next ❯

Citations

Dec 31, 2015·Journal of Medical Case Reports·Vipula R BataduwaarachchiNirmali Tissera
Aug 21, 2015·Current Rheumatology Reports·Md Yuzaiful Md YusofMaya H Buch
Jun 1, 2016·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jan-Stephan F SandersCoen A Stegeman
Jun 19, 2016·QJM : Monthly Journal of the Association of Physicians·B A McNicholasM D Griffin
Aug 2, 2016·Clinical Kidney Journal·Juliana Bordignon DraibeAlan David Salama
Dec 2, 2015·Annals of the Rheumatic Diseases·Sebastian UnizonyUNKNOWN RAVE-ITN Research Group
Sep 7, 2016·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Damien NooneChristoph Licht
Jan 15, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Divi CornecUlrich Specks
Apr 4, 2017·Immunology and Allergy Clinics of North America·Rachel M Wolfe, Dennis C Ang
Jun 18, 2017·Internal and Emergency Medicine·Benjamin Chaigne, Loïc Guillevin
Jan 8, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Lucy A PlumbKjell Tullus
Dec 5, 2017·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Kofi A MensahAbhijeet Danve
Feb 21, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Stephen P McAdooCharles D Pusey
Dec 6, 2017·Zeitschrift für Rheumatologie·Jan Henrik SchirmerFrank Moosig
Dec 3, 2016·Annals of the Rheumatic Diseases·Emma E van DaalenChinar Rahmattulla
Sep 25, 2015·The Cochrane Database of Systematic Reviews·Giles WaltersJonathan C Craig
Feb 21, 2018·Clinical Reviews in Allergy & Immunology·Xiao XiaoXiong Ma
Sep 4, 2018·Expert Review of Clinical Immunology·Eric J CampbellRosalind Ramsey-Goldman
Jan 8, 2019·The Korean Journal of Internal Medicine·Masayoshi HarigaiKenji Nagasaka
Dec 1, 2018·Practical Neurology·Daniel H WhittamAnu Jacob
Jun 28, 2016·F1000Research·Matthew J Koster, Kenneth J Warrington
Jan 7, 2019·Annals of the Rheumatic Diseases·Rachel B JonesUNKNOWN European Vasculitis Study Group (EUVAS)
Sep 28, 2018·Neurology. Neuroimmunology and Neuroinflammation·Andrea MarcinnòAntonio Bertolotto
Jul 1, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Laura S van DamYoe K Onno Teng
Apr 16, 2020·Expert Opinion on Biological Therapy·Loïc Raffray, Loïc Guillevin
Jan 11, 2020·BMJ Case Reports·Daryl R ChengRomy Cho
Dec 10, 2016·Zeitschrift für Rheumatologie·S SchinkeP Lamprecht
Feb 6, 2017·Current Rheumatology Reports·Romina I Hassan, Angelo L Gaffo
Aug 16, 2018·Nature Reviews. Rheumatology·Mark McClureRachel Jones
Sep 12, 2018·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Keiji Akamine, Marilynn Punaro
Nov 26, 2019·Expert Review of Clinical Immunology·Alvise Berti, Ulrich Specks
Aug 23, 2020·Journal of the American Society of Nephrology : JASN·Marta Casal MouraFernando C Fervenza

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Rachel B JonesEuropean Vasculitis Study Group
The New England Journal of Medicine
Loïc GuillevinFrench Vasculitis Study Group
The New England Journal of Medicine
Ulrich SpecksRAVE-ITN Research Group
The New England Journal of Medicine
Christian PagnouxMAINRITSAN investigators
The New England Journal of Medicine
Frédéric Vandergheynst
© 2022 Meta ULC. All rights reserved